Global Companion Diagnostic Tests in Oncology Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Publisher Name :
Date: 13-Sep-2018
No. of pages: 118

Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.

Scope of the Report:

This report studies the Companion Diagnostic Tests in Oncology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Companion Diagnostic Tests in Oncology market by product type and applications/end industries.

The global Companion Diagnostic Tests in Oncology market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Companion Diagnostic Tests in Oncology.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

-Abbott

-Roche

-Genomic Health

-QIAGEN

-Agilent

-Agendia

-BioMerieux

-Illumina

-Siemens Healthcare

-Thermo Fisher

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

-Protein Detection

-DNA Detection

Market Segment by Applications, can be divided into

-Pharmaceutical & Biotechnology Companies

-Medical Device Companies

-Research Institutes

Global Companion Diagnostic Tests in Oncology Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents
1 Companion Diagnostic Tests in Oncology Market Overview
1.1 Product Overview and Scope of Companion Diagnostic Tests in Oncology
1.2 Classification of Companion Diagnostic Tests in Oncology by Types
1.2.1 Global Companion Diagnostic Tests in Oncology Revenue Comparison by Types (2017-2023)
1.2.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Types in 2017
1.2.3 Protein Detection
1.2.4 DNA Detection
1.3 Global Companion Diagnostic Tests in Oncology Market by Application
1.3.1 Global Companion Diagnostic Tests in Oncology Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Medical Device Companies
1.3.4 Research Institutes
1.4 Global Companion Diagnostic Tests in Oncology Market by Regions
1.4.1 Global Companion Diagnostic Tests in Oncology Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)
1.5 Global Market Size of Companion Diagnostic Tests in Oncology (2013-2023)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Companion Diagnostic Tests in Oncology Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 Companion Diagnostic Tests in Oncology Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.3 Genomic Health
2.3.1 Business Overview
2.3.2 Companion Diagnostic Tests in Oncology Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.4 QIAGEN
2.4.1 Business Overview
2.4.2 Companion Diagnostic Tests in Oncology Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.5 Agilent
2.5.1 Business Overview
2.5.2 Companion Diagnostic Tests in Oncology Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.6 Agendia
2.6.1 Business Overview
2.6.2 Companion Diagnostic Tests in Oncology Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.7 BioMerieux
2.7.1 Business Overview
2.7.2 Companion Diagnostic Tests in Oncology Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.8 Illumina
2.8.1 Business Overview
2.8.2 Companion Diagnostic Tests in Oncology Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.9 Siemens Healthcare
2.9.1 Business Overview
2.9.2 Companion Diagnostic Tests in Oncology Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.10 Thermo Fisher
2.10.1 Business Overview
2.10.2 Companion Diagnostic Tests in Oncology Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
3 Global Companion Diagnostic Tests in Oncology Market Competition, by Players
3.1 Global Companion Diagnostic Tests in Oncology Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Companion Diagnostic Tests in Oncology Players Market Share
3.2.2 Top 10 Companion Diagnostic Tests in Oncology Players Market Share
3.3 Market Competition Trend
4 Global Companion Diagnostic Tests in Oncology Market Size by Regions
4.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Regions
4.2 North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
4.3 Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
4.5 South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
5 North America Companion Diagnostic Tests in Oncology Revenue by Countries
5.1 North America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)
5.2 USA Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
5.3 Canada Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
5.4 Mexico Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
6 Europe Companion Diagnostic Tests in Oncology Revenue by Countries
6.1 Europe Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)
6.2 Germany Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
6.3 UK Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
6.4 France Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
6.5 Russia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
6.6 Italy Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue by Countries
7.1 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)
7.2 China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
7.3 Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
7.4 Korea Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
7.5 India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
8 South America Companion Diagnostic Tests in Oncology Revenue by Countries
8.1 South America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)
8.2 Brazil Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
8.3 Argentina Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
8.4 Colombia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Companion Diagnostic Tests in Oncology by Countries
9.1 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)
9.2 Saudi Arabia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
9.3 UAE Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
9.4 Egypt Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
9.5 Nigeria Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
9.6 South Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
10 Global Companion Diagnostic Tests in Oncology Market Segment by Type
10.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Type (2013-2018)
10.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Type (2018-2023)
10.3 Protein Detection Revenue Growth Rate (2013-2023)
10.4 DNA Detection Revenue Growth Rate (2013-2023)
11 Global Companion Diagnostic Tests in Oncology Market Segment by Application
11.1 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2013-2018)
11.2 Companion Diagnostic Tests in Oncology Market Forecast by Application (2018-2023)
11.3 Pharmaceutical & Biotechnology Companies Revenue Growth (2013-2018)
11.4 Medical Device Companies Revenue Growth (2013-2018)
11.5 Research Institutes Revenue Growth (2013-2018)
12 Global Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2023)
12.1 Global Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2023)
12.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Regions (2018-2023)
12.3 North America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
12.4 Europe Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
12.6 South America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Companion Diagnostic Tests in Oncology Picture
Table Product Specifications of Companion Diagnostic Tests in Oncology
Table Global Companion Diagnostic Tests in Oncology and Revenue (Million USD) Market Split by Product Type
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Types in 2017
Figure Protein Detection Picture
Figure DNA Detection Picture
Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Application (2013-2023)
Figure Companion Diagnostic Tests in Oncology Revenue Market Share by Applications in 2017
Figure Pharmaceutical & Biotechnology Companies Picture
Figure Medical Device Companies Picture
Figure Research Institutes Picture
Table Global Market Companion Diagnostic Tests in Oncology Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Companion Diagnostic Tests in Oncology Type and Applications
Table Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Companion Diagnostic Tests in Oncology Type and Applications
Table Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Genomic Health Basic Information, Manufacturing Base and Competitors
Table Genomic Health Companion Diagnostic Tests in Oncology Type and Applications
Table Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table QIAGEN Basic Information, Manufacturing Base and Competitors
Table QIAGEN Companion Diagnostic Tests in Oncology Type and Applications
Table QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Agilent Basic Information, Manufacturing Base and Competitors
Table Agilent Companion Diagnostic Tests in Oncology Type and Applications
Table Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Agendia Basic Information, Manufacturing Base and Competitors
Table Agendia Companion Diagnostic Tests in Oncology Type and Applications
Table Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table BioMerieux Basic Information, Manufacturing Base and Competitors
Table BioMerieux Companion Diagnostic Tests in Oncology Type and Applications
Table BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Illumina Basic Information, Manufacturing Base and Competitors
Table Illumina Companion Diagnostic Tests in Oncology Type and Applications
Table Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table Siemens Healthcare Companion Diagnostic Tests in Oncology Type and Applications
Table Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Companion Diagnostic Tests in Oncology Type and Applications
Table Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Players (2013-2018)
Table Global Companion Diagnostic Tests in Oncology Revenue Share by Players (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Players in 2016
Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Players in 2017
Figure Global Top 5 Players Companion Diagnostic Tests in Oncology Revenue Market Share in 2017
Figure Global Top 10 Players Companion Diagnostic Tests in Oncology Revenue Market Share in 2017
Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Regions (2013-2018)
Table Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions in 2017
Figure North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Table North America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)
Table North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017
Figure USA Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Canada Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Mexico Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Table Europe Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018)
Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017
Figure Germany Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure UK Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure France Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Russia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Italy Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017
Figure China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Korea Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Table South America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)
Table South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017
Figure Brazil Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Argentina Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Colombia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017
Figure Saudi Arabia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure UAE Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Egypt Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure Nigeria Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Figure South Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)
Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Type (2013-2018)
Table Global Companion Diagnostic Tests in Oncology Revenue Share by Type (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Type (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Type in 2017
Table Global Companion Diagnostic Tests in Oncology Revenue Forecast by Type (2018-2023)
Figure Global Companion Diagnostic Tests in Oncology Market Share Forecast by Type (2018-2023)
Figure Global Protein Detection Revenue Growth Rate (2013-2018)
Figure Global DNA Detection Revenue Growth Rate (2013-2018)
Table Global Companion Diagnostic Tests in Oncology Revenue by Application (2013-2018)
Table Global Companion Diagnostic Tests in Oncology Revenue Share by Application (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Application (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Application in 2017
Table Global Companion Diagnostic Tests in Oncology Revenue Forecast by Application (2018-2023)
Figure Global Companion Diagnostic Tests in Oncology Market Share Forecast by Application (2018-2023)
Figure Global Pharmaceutical & Biotechnology Companies Revenue Growth Rate (2013-2018)
Figure Global Medical Device Companies Revenue Growth Rate (2013-2018)
Figure Global Research Institutes Revenue Growth Rate (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
Figure South America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)
  • Global Hip Replacement Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 116
    Hip replacement is a surgical procedure in which the hip joint is replaced by a prosthetic implant, that is, a hip prosthesis. Hip replacement surgery can be performed as a total replacement or a hemi replacement. Scope of the Report: The demand of hip replacement implant will steadfast growth in the coming years. The surging demand for hip replacement surgeries coupled with rising clinical awareness among patients is fuelling the hip replacement implant market. Increasing ......
  • Global Hip Resurfacing Implants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 135
    Hip resurfacing is a technique designed to reline the worn out joint, instead of being replaced completely as in total hip replacement procedure. In hip resurfacing the femoral head is not removed, instead it is trimmed and resurfaced with smooth metal covering. Scope of the Report: Hip resurfacing creates bigger hip ball than generally used in hip replacement, which reduces the risk of dislocation. Hip resurfacing provide active and improved quality of life which is done b......
  • Global Histoplasmosis Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 121
    Histoplasmosis is an infection that occurs from breathing spores of a fungus called Histoplasma capsulatum. Histoplasmosis is a fungal infection that occurs throughout the world. Histoplasma fungus grows as a mold in the soil. The soil that contains the droppings of bat or birds usually contains large amount of this fungus. The people with weakened immune system are usually more prone and increases the risk of being affected or reactivated with histoplasmosis. Usually people very young, old peop......
  • Global HIV Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 121
    The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease. Scope of the Report: HIV spreads through fluidic exchange with some infected person such as blood transfer or sharing needles with someone who is HIV infected. In addition, HIV can spread from infected moth......
  • Global HIV-AIDS Testing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 136
    HIV-AIDS is a chronic disease caused by the human immunodeficiency virus (HIV). HIV virus damages human immune system, which results weakness of immune system and loss ability to fight with organism that causes disease. HIV-AIDS most often spread through unprotected sex with HIV infected person. In addition, HIV-AIDS can also be spread from infected mother to child during pregnancy, infected blood and sharing needles with someone who has HIV-AIDS. Some of the symptoms of HIV inclu......
  • Global Home Infusion Therapy Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 121
    Home infusion therapy facilitates the intravenous administration of medicines into the body of a patient with a needle or catheter. It is prescribed by physicians and administered by trained professionals and nurses. It is used when oral medication is not effective for the treatment of diseases. It reduces the time spent by patients in hospitals, nursing homes and clinics. It includes continuous and slow administration of drugs, antibiotics, nutrients and other fluids into the veins on a daily, ......
  • Global Home Infusion Therapy Services Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 119
    Home infusion therapy services offer an innovative healthcare services at the doorsteps. Infusion therapy administer medication through needle or a catheter. Infusion therapy is generally used when the patient's condition is very severe and cannot be cured with the oral medication. Home infusion is best described as most convenient for patient particularly when the infusion is needed multiple times in a day or long term care. Disease which need infusion therapies include cancer and cancer relate......
  • Global Hormone Refractory Prostate Cancer Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 100
    Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, intensifying HRPCA prevalence and fast-emerging treatment modifications, the global HRPCA market is poised to witness an unprecedented growth. Scope of the Report: The global Hor......
  • Global Hospice Services Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Hospice services are cost-effective humane and compassionate care services provided to the patients who are in the last phase of their life and have completed the medical treatment course for incurable diseases such as congestive heart failure, cancer, dementia and lung disease. These services focus on the quality of the life instead of its length so that patients may live with maximum comfort in their last days. Scope of the Report: Usually hospice services are used when a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs